Dr. Daniel Youngjun Choi, MD

Dr. Choi practices at Valley Laser & Surgery Center in Stockton, California.

Dr. Choi's NPI, 1801164827, was assigned on December 5, 2011. Dr. Choi graduated from David Geffen School of Medicine at UCLA in 2011. Dr. Choi holds California license A122048.

Dr. Choi's primary practice is Valley Laser & Surgery Center, at 36 West Yokuts Avenue, Suite 3, Stockton, CA 95207. The practice phone is (209) 952-1189.

Dr. Choi's primary practice is Valley Laser & Surgery Center in Stockton, California. Dr. Choi is also affiliated with Doctors Hospital of Manteca. Dmand AI also links Dr. Choi to 2 more group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Choi practices, 4 sites in all. Vendor and product names are available with a free account.

Ophthalmology is Dr. Choi's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Choi is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Choi is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, cataract surgery with lens implant, conjunctivitis, dry eye, eye infection or inflammation, glaucoma and glaucoma surgery among the conditions Dr. Choi treats.

CMS data shows 4,860 Medicare services from Dr. Choi across 19 procedure codes in 2024, for 1,173 Medicare patients. Medicare paid $417,969 for them.

CMS counts 1,173 Medicare patients who saw Dr. Choi in 2024. The largest group is 75 to 84, with 474 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 27% are also on Medicaid. Their average risk score is 1.28, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Choi's median patient age at 73, with 58% women.

In 2024, Dr. Choi wrote 11,290 Medicare Part D claims for 1,673 patients. 60% of them were for generic drugs. CMS names the drug for 11,215 of them, across 27 drugs with 11 or more claims each, at $1,015,535 in total drug cost. In 2023, CMS named 8,929 claims across 27 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Dr. Choi for performance year 2024, reported as part of a group. Dr. Choi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 343 procedures of cataract surgery by Dr. Choi, more than 91% of the clinicians it reports for that procedure.

Dmand AI links 3 papers to Dr. Choi. The most frequent topics are Intraocular Pressure, Cataract and Ocular Hypertension. Dr. Choi's most frequent co-authors are Kuldev Singh, MD, Robert T. Chang, MD and Anjum Sharif Cheema, MD.

CMS Open Payments shows 178 general payments to Dr. Choi from 29 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 52% of the total. RxSight Inc paid the most, $4,965.

Dr. Choi graduated from David Geffen School of Medicine at UCLA in 2011.

Dr. Choi is in network with 20 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.